查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106311

個人化功能營養市場預測至2034年－全球產品類型、健康益處、技術、通路、應用、最終用戶和地區分析

Personalized Functional Nutrition Market Forecasts to 2034 - Global Analysis By Product Type, Health Benefit, Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球個人化功能營養市場預計將在 2026 年達到 127 億美元，並在預測期內以 14.6% 的複合年成長率成長，到 2034 年達到 288 億美元。

個人化功能營養是指根據個人的生物數據（包括基因譜、微生物群組成、生物標記水平和生活方式參數）配製、推薦和客製化的食品、補充劑和營養干預措施，旨在最佳化健康益處並滿足特定的生理需求。這些產品利用人工智慧 (AI) 演算法、數位健康平台和先進的分析技術，從個人的健康數據中提取有針對性的營養配方、膳食計劃和補充劑攝入方案，並考慮其代謝變異性、營養吸收效率和疾病風險狀況，而不是應用通用的、基於人群的膳食指南。

數位健康數據的激增

穿戴式健身追蹤器、家用基因檢測套組、微生物組分析服務和連續血糖監測儀等消費者健康數據的指數級成長，為開發數據驅動型個人化營養產品創造了前所未有的成長機會。消費者越來越期望獲得根據其獨特生物特徵量身定做的健康建議，而數位健康平台和電子商務系統的整合，使得生物標記數據能夠無縫融入個人化營養補充劑訂閱和機能性食品推薦中，從而構建永續的收入模式。

缺乏臨床療效證據

由於缺乏大規模隨機對照試驗來證實個人化營養干預比標準飲食指導更能帶來更好的健康結果，因此，醫療保健專業人員和監管機構普遍對產品功效聲明持懷疑態度。基因與營養素相互作用的複雜性以及環境因素對微生物組組成的影響，使得難以在個性化建議與可衡量的健康改善之間建立一致的因果關係，這阻礙了醫療保健專業人員的建議和保險覆蓋範圍的擴大。

融入慢性病管理

隨著全球糖尿病、心血管疾病和METABOLIC INC.症候群盛行率的上升，人們對營養干預的需求顯著增加，這些干預措施旨在解決個體與飲食相關的風險因素和透過生物標記檢測確定的營養素缺乏問題，並作為藥物治療的補充。醫療保健系統和保險公司為了降低長期治療成本，正日益重視將個人化營養方案納入預防性醫療給付的範疇；與此同時，製藥公司也在開發輔助營養產品，透過靶向補充微量營養素來增強藥物療效。

與資料隱私相關的監管風險

為了提供個人化營養方案，企業需要收集和分析敏感的基因、微生物組和生物標記數據，這使得它們面臨不斷變化的數據隱私法規的挑戰，包括歐洲的《通用資料保護條例》(GDPR) 和新的基因資訊保護法，這些法律對同意、儲存和共用提出了嚴格的要求。消費者擔心保險公司、雇主或第三方濫用生物數據，這可能會降低他們參與個人化營養方案的意願。同時，監管機構對資料保護措施不完善的行為所採取的執法行動，可能會導致巨額罰款和聲譽損害。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了數位醫療服務和遠距健康監測的普及，隨著消費者逐漸習慣居家健康檢查和線上諮詢，個人化營養平台的發展基礎設施也隨之建立。疫情後，人們對免疫健康和代謝韌性的關注度顯著提升，推動了針對個人免疫特徵和發炎指標的個人化營養補充劑的需求。此外，醫療系統數位化的投資也提高了電子健康記錄（EHR）與營養推薦平台之間的互通性。

在預測期內，個人化營養補充品細分市場預計將佔據最大的市場佔有率。

預計在預測期內，個人化膳食補充劑細分市場將佔據最大的市場佔有率。這是因為膳食補充劑是目前最方便、商業性程度最高的個人化營養形式，可透過直接面對消費者 (DTC) 的訂閱模式和零售商客製化服務實現。成熟的全球膳食補充劑市場為消費者提供了熟悉的個人化產品入口，而且與生產複雜的機能性食品相比，客製化膠囊和粉末配方的生產相對簡單，這使得個人化膳食補充劑業務能夠快速擴張。

預計在預測期內，認知健康領域將呈現最高的複合年成長率。

在預測期內，認知健康領域預計將呈現最高的成長率，這主要得益於已開發市場人口老化以及人們對特定營養素、腸道菌群組成和認知功能之間關係的科學認知不斷加深。消費者對與老齡化相關的認知能力下降的擔憂以及神經退化性疾病診斷率的上升，正在推動對個人化益智藥和腦健康支持配方的投資。此外，數位化認知功能評估工具能夠客觀地追蹤介入效果，進而促進消費者重複購買。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這是因為美國擁有最先進的直接面對消費者（DTC）健康檢測生態系統，消費者對基因檢測、微生物組分析和生物標記監測服務的認知度已經很高。包括Viome Life Sciences, Inc.和Thorne HealthTech, Inc.在內的領先個人化營養公司總部均設在北美，其數位健康平台擁有龐大的用戶群，同時，創業投資對精準健康新創公司的投資成長速度也高於其他地區。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本和韓國數位醫療的快速普及，以及各國政府為推廣預防醫學和健康老齡化戰略而採取的各項舉措。該地區大規模的老齡人口和日益加重的慢性病負擔，催生了對個性化預防營養的強勁結構性需求；同時，先進的行動支付基礎設施和電子商務的蓬勃發展，也為健康數據的收集及其與個性化產品購買和配送系統的無縫整合提供了支持。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球個人化功能營養市場：依產品類型分類

  • 個人化營養補充品
  • 個人化機能性食品
  • 個性化機能飲料
  • 個人化營養粉
  • 個人化營養棒
  • 個性化代餐產品
  • 其他產品類型

第6章：全球個人化功能營養市場：依健康效益分類

  • 免疫健康
  • 腸道健康
  • 體重管理
  • 認知健康
  • 心臟健康
  • 運動營養
  • 健康老化

第7章 全球個人化功能營養市場：依技術分類

  • 人工智慧驅動的營養
  • 基於基因檢測的營養方案
  • 微生物組分析
  • 穿戴式裝置的整合
  • 數位營養平台
  • 基於生物標記的營養計劃

第8章：全球個人化功能營養市場：按分銷管道分類

  • 線上平台
  • 直接面對消費者
  • 藥局
  • 超級市場和大賣場
  • 專業營養食品店
  • 醫療服務提供方

第9章 全球個人化功能營養市場：依應用領域分類

  • 預防醫學
  • 臨床營養
  • 運動與健身
  • 女性健康
  • 男性健康
  • 保持健康的生活方式

第10章：全球個人化功能營養市場：依最終用戶分類

  • 成人
  • 孩子們
  • 老年人
  • 運動員
  • 慢性病患者
  • 注重健康的消費者

第11章 全球個人化功能營養市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Nestle Health Science
  • Herbalife Ltd.
  • Abbott Laboratories
  • Amway Corporation
  • DSM-Firmenich AG
  • Danone SA
  • Bayer AG
  • Haleon plc
  • Thorne HealthTech, Inc.
  • Bioniq Health-Tech Solutions Ltd.
  • Viome Life Sciences, Inc.
  • Zoe Limited
  • Persona Nutrition
  • Care/of
  • InsideTracker
  • Wellory
  • DayTwo Ltd.
Product Code: SMRC38530

According to Stratistics MRC, the Global Personalized Functional Nutrition Market is accounted for $12.7 billion in 2026 and is expected to reach $28.8 billion by 2034 growing at a CAGR of 14.6% during the forecast period. Personalized functional nutrition refers to dietary products, supplements, and nutritional interventions that are formulated, recommended, or customized based on individual biological data including genetic profiles, microbiome composition, biomarker levels, and lifestyle parameters to optimize health outcomes and address specific physiological needs. These products leverage artificial intelligence algorithms, digital health platforms, and advanced analytical technologies to translate personal health data into targeted nutrient formulations, meal plans, and supplement regimens that account for individual metabolic variations, nutrient absorption efficiencies, and disease risk profiles rather than applying generic population-based dietary guidelines.

Market Dynamics:

Driver:

Digital Health Data Proliferation

The exponential growth in consumer-generated health data from wearable fitness trackers, at-home genetic testing kits, microbiome analysis services, and continuous glucose monitors is creating unprecedented opportunities to develop data-driven personalized nutrition products. Consumers increasingly expect health recommendations tailored to their unique biological profiles, while integration between digital health platforms and e-commerce systems enables seamless translation of biomarker data into personalized supplement subscriptions and functional food recommendations that drive recurring revenue models.

Restraint:

Clinical Validation Deficits

The limited body of large-scale randomized controlled trials demonstrating superior health outcomes from personalized nutrition interventions compared to standard dietary recommendations creates skepticism among healthcare providers and regulatory authorities regarding product efficacy claims. The complexity of gene-nutrient interactions and the influence of environmental variables on microbiome composition make it difficult to establish consistent causal relationships between personalized recommendations and measurable health improvements, which constrains medical professional endorsement and insurance reimbursement coverage.

Opportunity:

Chronic Disease Management Integration

Rising global prevalence of diabetes, cardiovascular disease, and metabolic syndrome is creating substantial demand for nutrition interventions that complement pharmaceutical treatments by addressing individual dietary risk factors and nutrient deficiencies identified through biomarker testing. Healthcare systems and insurance providers seeking to reduce long-term treatment costs are increasingly evaluating personalized nutrition programs for covered preventive care benefits, while pharmaceutical companies are exploring companion nutrition products that enhance drug efficacy through targeted micronutrient support.

Threat:

Data Privacy Regulatory Risk

The collection and analysis of sensitive genetic, microbiome, and biomarker data for personalized nutrition purposes exposes companies to evolving data privacy regulations including GDPR in Europe and emerging genetic information protection laws that impose strict consent, storage, and sharing requirements. Consumer concerns regarding the potential misuse of biological data by insurance companies, employers, or third parties can limit willingness to participate in personalized nutrition programs, while regulatory enforcement actions against inadequate data protection practices can result in substantial fines and reputational damage.

Covid-19 Impact:

COVID-19 accelerated adoption of digital health services and remote wellness monitoring that provided foundational infrastructure for personalized nutrition platform growth, as consumers became accustomed to at-home health testing and virtual consultations. Post-pandemic emphasis on immune health and metabolic resilience has strengthened demand for personalized supplements targeting individual immune profiles and inflammation markers, while healthcare system digitization investments have improved interoperability between electronic health records and nutrition recommendation platforms.

The personalized dietary supplements segment is expected to be the largest during the forecast period

The personalized dietary supplements segment is expected to account for the largest market share during the forecast period, due to supplements representing the most accessible and commercially mature format for delivering personalized nutrition through direct-to-consumer subscription models and retail customization services. The established global dietary supplement market provides a familiar consumer entry point for personalized products, while the relatively straightforward manufacturing of customized capsule and powder formulations enables rapid scaling of personalized supplement businesses compared to complex functional food production.

The cognitive health segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cognitive health segment is predicted to witness the highest growth rate, driven by aging populations across developed markets and increasing scientific understanding of the relationships between specific nutrients, gut microbiome composition, and cognitive function. Consumer anxiety regarding age-related cognitive decline and the rising diagnosis rates of neurodegenerative conditions are fueling investment in personalized nootropic and brain health formulations, while digital cognitive assessment tools enable objective tracking of intervention efficacy that supports repeat purchase behavior.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the United States possessing the most advanced direct-to-consumer health testing ecosystem with established consumer familiarity with genetic testing, microbiome analysis, and biomarker monitoring services. Leading personalized nutrition companies including Viome Life Sciences, Inc. and Thorne HealthTech, Inc. are headquartered in North America and maintain extensive digital health platform user bases, while venture capital investment in precision health startups continues to outpace other regions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding digital health adoption across China, Japan, and South Korea combined with government initiatives promoting preventive healthcare and healthy aging strategies. The region's large aging populations and rising chronic disease burden create strong structural demand for personalized preventive nutrition, while advanced mobile payment infrastructure and e-commerce penetration support seamless integration of health data collection with personalized product purchasing and delivery systems.

Key players in the market

Some of the key players in Personalized Functional Nutrition Market include Nestle Health Science, Herbalife Ltd., Abbott Laboratories, Amway Corporation, DSM-Firmenich AG, Danone S.A., Bayer AG, Haleon plc, Thorne HealthTech, Inc., Bioniq Health-Tech Solutions Ltd., Viome Life Sciences, Inc., Zoe Limited, Persona Nutrition, Care/of, InsideTracker, Wellory and DayTwo Ltd..

Key Developments:

In June 2026, Nestle Health Science launched an AI-powered personalized nutrition platform integrating continuous glucose monitor data with microbiome analysis to generate real-time supplement recommendations for metabolic health optimization.

In May 2026, Viome Life Sciences, Inc. expanded its personalized supplement subscription service to European markets, leveraging its RNA-based microbiome testing technology to deliver customized formulations across gut health and immune function categories.

In April 2026, Abbott Laboratories secured FDA clearance for its biomarker-based personalized nutrition diagnostic system, enabling healthcare providers to prescribe targeted nutritional interventions based on individual metabolic panel results.

Product Types Covered:

  • Personalized Dietary Supplements
  • Personalized Functional Foods
  • Personalized Functional Beverages
  • Personalized Nutrition Powders
  • Personalized Nutrition Bars
  • Personalized Meal Replacements
  • Other Product Type

Health Benefits Covered:

  • Immune Health
  • Gut Health
  • Weight Management
  • Cognitive Health
  • Heart Health
  • Sports Nutrition
  • Healthy Aging

Technologies Covered:

  • Artificial Intelligence-Based Nutrition
  • Genetic Testing-Based Nutrition
  • Microbiome Analysis
  • Wearable Device Integration
  • Digital Nutrition Platforms
  • Biomarker-Based Nutrition Planning

Distribution Channels Covered:

  • Online Platforms
  • Direct-to-Consumer
  • Pharmacies
  • Supermarkets and Hypermarkets
  • Specialty Nutrition Stores
  • Healthcare Providers

Applications Covered:

  • Preventive Healthcare
  • Clinical Nutrition
  • Sports and Fitness
  • Women's Health
  • Men's Health
  • Healthy Lifestyle Management

End Users Covered:

  • Adults
  • Children
  • Senior Citizens
  • Athletes
  • Patients with Chronic Conditions
  • Health-Conscious Consumers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Personalized Functional Nutrition Market, By Product Type

  • 5.1 Personalized Dietary Supplements
  • 5.2 Personalized Functional Foods
  • 5.3 Personalized Functional Beverages
  • 5.4 Personalized Nutrition Powders
  • 5.5 Personalized Nutrition Bars
  • 5.6 Personalized Meal Replacements
  • 5.7 Other Product Type

6 Global Personalized Functional Nutrition Market, By Health Benefit

  • 6.1 Immune Health
  • 6.2 Gut Health
  • 6.3 Weight Management
  • 6.4 Cognitive Health
  • 6.5 Heart Health
  • 6.6 Sports Nutrition
  • 6.7 Healthy Aging

7 Global Personalized Functional Nutrition Market, By Technology

  • 7.1 Artificial Intelligence-Based Nutrition
  • 7.2 Genetic Testing-Based Nutrition
  • 7.3 Microbiome Analysis
  • 7.4 Wearable Device Integration
  • 7.5 Digital Nutrition Platforms
  • 7.6 Biomarker-Based Nutrition Planning

8 Global Personalized Functional Nutrition Market, By Distribution Channel

  • 8.1 Online Platforms
  • 8.2 Direct-to-Consumer
  • 8.3 Pharmacies
  • 8.4 Supermarkets and Hypermarkets
  • 8.5 Specialty Nutrition Stores
  • 8.6 Healthcare Providers

9 Global Personalized Functional Nutrition Market, By Application

  • 9.1 Preventive Healthcare
  • 9.2 Clinical Nutrition
  • 9.3 Sports and Fitness
  • 9.4 Women's Health
  • 9.5 Men's Health
  • 9.6 Healthy Lifestyle Management

10 Global Personalized Functional Nutrition Market, By End User

  • 10.1 Adults
  • 10.2 Children
  • 10.3 Senior Citizens
  • 10.4 Athletes
  • 10.5 Patients with Chronic Conditions
  • 10.6 Health-Conscious Consumers

11 Global Personalized Functional Nutrition Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Nestle Health Science
  • 14.2 Herbalife Ltd.
  • 14.3 Abbott Laboratories
  • 14.4 Amway Corporation
  • 14.5 DSM-Firmenich AG
  • 14.6 Danone S.A.
  • 14.7 Bayer AG
  • 14.8 Haleon plc
  • 14.9 Thorne HealthTech, Inc.
  • 14.10 Bioniq Health-Tech Solutions Ltd.
  • 14.11 Viome Life Sciences, Inc.
  • 14.12 Zoe Limited
  • 14.13 Persona Nutrition
  • 14.14 Care/of
  • 14.15 InsideTracker
  • 14.16 Wellory
  • 14.17 DayTwo Ltd.

List of Tables

  • Table 1 Global Personalized Functional Nutrition Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Personalized Functional Nutrition Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Personalized Functional Nutrition Market Outlook, By Personalized Dietary Supplements (2023-2034) ($MN)
  • Table 4 Global Personalized Functional Nutrition Market Outlook, By Personalized Functional Foods (2023-2034) ($MN)
  • Table 5 Global Personalized Functional Nutrition Market Outlook, By Personalized Functional Beverages (2023-2034) ($MN)
  • Table 6 Global Personalized Functional Nutrition Market Outlook, By Personalized Nutrition Powders (2023-2034) ($MN)
  • Table 7 Global Personalized Functional Nutrition Market Outlook, By Personalized Nutrition Bars (2023-2034) ($MN)
  • Table 8 Global Personalized Functional Nutrition Market Outlook, By Personalized Meal Replacements (2023-2034) ($MN)
  • Table 9 Global Personalized Functional Nutrition Market Outlook, By Other Product Type (2023-2034) ($MN)
  • Table 10 Global Personalized Functional Nutrition Market Outlook, By Health Benefit (2023-2034) ($MN)
  • Table 11 Global Personalized Functional Nutrition Market Outlook, By Immune Health (2023-2034) ($MN)
  • Table 12 Global Personalized Functional Nutrition Market Outlook, By Gut Health (2023-2034) ($MN)
  • Table 13 Global Personalized Functional Nutrition Market Outlook, By Weight Management (2023-2034) ($MN)
  • Table 14 Global Personalized Functional Nutrition Market Outlook, By Cognitive Health (2023-2034) ($MN)
  • Table 15 Global Personalized Functional Nutrition Market Outlook, By Heart Health (2023-2034) ($MN)
  • Table 16 Global Personalized Functional Nutrition Market Outlook, By Sports Nutrition (2023-2034) ($MN)
  • Table 17 Global Personalized Functional Nutrition Market Outlook, By Healthy Aging (2023-2034) ($MN)
  • Table 18 Global Personalized Functional Nutrition Market Outlook, By Technology (2023-2034) ($MN)
  • Table 19 Global Personalized Functional Nutrition Market Outlook, By Artificial Intelligence-Based Nutrition (2023-2034) ($MN)
  • Table 20 Global Personalized Functional Nutrition Market Outlook, By Genetic Testing-Based Nutrition (2023-2034) ($MN)
  • Table 21 Global Personalized Functional Nutrition Market Outlook, By Microbiome Analysis (2023-2034) ($MN)
  • Table 22 Global Personalized Functional Nutrition Market Outlook, By Wearable Device Integration (2023-2034) ($MN)
  • Table 23 Global Personalized Functional Nutrition Market Outlook, By Digital Nutrition Platforms (2023-2034) ($MN)
  • Table 24 Global Personalized Functional Nutrition Market Outlook, By Biomarker-Based Nutrition Planning (2023-2034) ($MN)
  • Table 25 Global Personalized Functional Nutrition Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 26 Global Personalized Functional Nutrition Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 27 Global Personalized Functional Nutrition Market Outlook, By Direct-to-Consumer (2023-2034) ($MN)
  • Table 28 Global Personalized Functional Nutrition Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 29 Global Personalized Functional Nutrition Market Outlook, By Supermarkets and Hypermarkets (2023-2034) ($MN)
  • Table 30 Global Personalized Functional Nutrition Market Outlook, By Specialty Nutrition Stores (2023-2034) ($MN)
  • Table 31 Global Personalized Functional Nutrition Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 32 Global Personalized Functional Nutrition Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 Global Personalized Functional Nutrition Market Outlook, By Preventive Healthcare (2023-2034) ($MN)
  • Table 34 Global Personalized Functional Nutrition Market Outlook, By Clinical Nutrition (2023-2034) ($MN)
  • Table 35 Global Personalized Functional Nutrition Market Outlook, By Sports and Fitness (2023-2034) ($MN)
  • Table 36 Global Personalized Functional Nutrition Market Outlook, By Women's Health (2023-2034) ($MN)
  • Table 37 Global Personalized Functional Nutrition Market Outlook, By Men's Health (2023-2034) ($MN)
  • Table 38 Global Personalized Functional Nutrition Market Outlook, By Healthy Lifestyle Management (2023-2034) ($MN)
  • Table 39 Global Personalized Functional Nutrition Market Outlook, By End User (2023-2034) ($MN)
  • Table 40 Global Personalized Functional Nutrition Market Outlook, By Adults (2023-2034) ($MN)
  • Table 41 Global Personalized Functional Nutrition Market Outlook, By Children (2023-2034) ($MN)
  • Table 42 Global Personalized Functional Nutrition Market Outlook, By Senior Citizens (2023-2034) ($MN)
  • Table 43 Global Personalized Functional Nutrition Market Outlook, By Athletes (2023-2034) ($MN)
  • Table 45 Global Personalized Functional Nutrition Market Outlook, By Patients with Chronic Conditions (2023-2034) ($MN)
  • Table 45 Global Personalized Functional Nutrition Market Outlook, By Health-Conscious Consumers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.